Venrock Closes 10th Fund at $650 Million

Palo Alto – January 8, 2024 – Cooley advised Venrock on the close of its 10th fund at $650 million. After raising approximately $450 million every three years throughout the past decade’s bull market, Venrock raised the $650 million for Venrock 10 to generate greater follow-on reserves in the current market environment. Partners Eric Doherty and John Clendenin led the Cooley team advising Venrock.

Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world’s most disruptive and successful companies. With a primary focus on technology and healthcare, Venrock’s portfolio companies have included 10X Genomics, Apple Computer, AveXis, Check Point Software, Cloudflare, Dollar Shave Club, Gilead Sciences, Idec Pharma, Illumina, Intel, Millennium Pharmaceuticals and Nest.

Cooley has advised Venrock on a range of matters since 2003, including its $450 million ninth fund in March 2021 and $450 million eighth fund in February 2017.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has more than 1,300 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of nearly 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.